Letícia Filice

Prof. Letícia Filice

Universidade Federal de Uberlândia, MG, Brazil
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2014 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
Letícia FiliceLetícia Filice
Letícia Filice
BBBellisa F Barbosa
Bellisa F Barbosa
MAMariana B Angeloni
Mariana B Angeloni
NSNeide M Silva
Neide M Silva
AGAngelica O Gomes
Angelica O Gomes
EFEloísa Ferro
Eloísa Ferro
Although Toxoplasma gondii infection is normally asymptomatic, severe cases of toxoplasmosis may occur in immunosuppressed patients or congenitally infected newborns. When a fetal infection is established, the recommended treatment is a combination of pyrimethamine, sulfadiazine and folinic acid (PSA). The aim of the present study was to evaluate the efficacy of azithromycin to control T. gondii infection in human villous explants.

18 August 2021 in Materials
Verified
Journal Article
Open access
PDF file
VAVivian Alonso-Goulart
Vivian Alonso-Goulart
LCLoyna Nobile Carvalho
Loyna Nobile Carvalho
AMAna Leticia Galante Marinho
Ana Leticia Galante Marinho
BSBianca Lourenço de Oliveira Souza
Bianca Lourenço de Oliveira Souza
GPGabriela Palis
Gabriela Palis
Letícia FiliceLetícia Filice
Letícia Filice
The use of biological templates for the suitable growth of adipose-derived mesenchymal stem cells (AD-MSC) and “neo-tissue” construction has exponentially increased over the last years. The bioengineered scaffolds still have a prominent and biocompatible framework playing a role in tissue regeneration. In order to supply AD-MSCs, biomaterials, as the stem cell niche, are more often supplemented by or stimulate molecular signals that allow differentiation events into several strains, besides their secretion of cytokines and effects of immunomodulation. This systematic review aims to highlight the details of the integration of several types of biomaterials used in association with AD-MSCs, collecting notorious and basic data of in vitro and in vivo assays, taking into account the relevance of the interference of the cell lineage origin and handling cell line protocols for both the replacement and repairing of damaged tissues or organs in clinical application. Our group analyzed the quality and results of the 98 articles selected from PubMed, Scopus and Web of Science. A total of 97% of the articles retrieved demonstrated the potential in clinical applications. The synthetic polymers were the most used biomaterials associated with AD-MSCs and almost half of the selected articles were applied on bone regeneration.

14 September 2020 in Materials
Verified
Journal Article
Open access
PDF file
CDCristiane Duarte
Cristiane Duarte
LGLuiz Ricardo Goulart
Luiz Ricardo Goulart
Letícia FiliceLetícia Filice
Letícia Filice
ILIsabela Lemos de Lima
Isabela Lemos de Lima
ECEsther Campos-Fernández
Esther Campos-Fernández
VAVivian Alonso-Goulart
Vivian Alonso-Goulart
Titanium dioxide (TiO2) is manufactured worldwide as crystalline and amorphous forms for multiple applications, including tissue engineering, but our study proposes analyzing the impact of crystalline phases of TiO2 on Mesenchymal Stem Cells (MSCs). Several studies have already described the regenerative potential of MSCs and TiO2 has been used for bone regeneration. In this study, polydispersity index and sizes of TiO2 nanocrystals (NCs) were determined. Adipose tissue-derived Mesenchymal Stem Cells (AT-MSCs) were isolated and characterized in order to evaluate cellular viability and the internalization of nanocrystals (NCs). All of the assays were performed using the TiO2 NCs with 100% anatase (A), 91.6% anatase/9.4% rutile (AR), 64.6% rutile/35.4% anatase (RA), and 84.0% rutile/16% brookite (RB), submitted to several concentrations in 24-h treatments. Cellular localization of TiO2 NCs in the AT-MSCs was resolved by europium-doped NCs. Viability was significantly improved under the predominance of the rutile phase in NCs with localization restricted at the cytoplasm, suggesting that AR and RA NCs are not genotoxic and can be associated with most cellular activities and metabolic pathways, including glycolysis and cell division.

29 October 2024 in Polymers
Verified
Journal Article
Open access
PDF file
Vanderlane Cavalcanti SilvaVanderlane Cavalcanti Silva
Vanderlane Cavalcanti Silva
DGDéborah dos Santos Gomes
Déborah dos Santos Gomes
EMEudes Leonan Gomes de Medeiros
Eudes Leonan Gomes de Medeiros
ASAdillys Marcelo da Cunha Santos
Adillys Marcelo da Cunha Santos
ILIsabela Lemos de Lima
Isabela Lemos de Lima
Romualdo R. MenezesRomualdo R. Menezes
Romualdo R. Menezes
This work presents the successful production of highly porous 3D nanofibrous hybrid scaffolds of polylactic acid (PLA)/polyethylene glycol (PEG) blends with the incorporation of calcium phosphate (CaP) bioceramics by a facile two-step process using the solution blow spinning (SBS) technique. CaP nanofibers were obtained at two calcium/phosphorus (Ca/P) ratios, 1.67 and 1.1, by SBS and calcination at 1000 °C. They were incorporated in PLA/PEG blends by SBS at 10 and 20 wt% to form 3D hybrid cotton-wool-like scaffolds. Morphological analysis showed that the fibrous scaffolds obtained had a randomly interconnected and highly porous structure. Also, the mean fiber diameter ranged from 408 ± 141 nm to 893 ± 496 nm. Apatite deposited considerably within 14 days in a simulated body fluid (SBF) test for hybrid scaffolds containing a mix of hydroxyapatite (HAp) and tri-calcium phosphate-β (β-TCP) phases. The scaffolds with 20 wt% CaP and a Ca/P ration of 1.1 showed better in vitro bioactivity to induce calcium mineralization for bone regeneration. Cellular tests evidenced that the developed scaffolds can support the osteogenic differentiation and proliferation of pre-osteoblastic MC3T3-E1 cells into mature osteoblasts. The results showed that the developed 3D scaffolds have potential applications for bone tissue engineering.

28 August 2024 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
LCLoyna Nobile Carvalho
Loyna Nobile Carvalho
LPLucas Correia Peres
Lucas Correia Peres
VAVivian Alonso-Goulart
Vivian Alonso-Goulart
BSBeatriz Jardim dos Santos
Beatriz Jardim dos Santos
MBMário Fernando Alves Braga
Mário Fernando Alves Braga
Letícia FiliceLetícia Filice
Letícia Filice
The skin is a tissue constantly exposed to the risk of damage, such as cuts, burns, and genetic disorders. The standard treatment is autograft, but it can cause pain to the patient being extremely complex in patients suffering from burns on large body surfaces. Considering that there is a need to develop technologies for the repair of skin tissue like 3D bioprinting. Skin is a tissue that is approximately 1/16 of the total body weight and has three main layers: epidermis, dermis, and hypodermis. Therefore, there are several studies using cells, biomaterials, and bioprinting for skin regeneration. Here, we provide an overview of the structure and function of the epidermis, dermis, and hypodermis, and showed in the recent research in skin regeneration, the main cells used, biomaterials studied that provide initial support for these cells, allowing the growth and formation of the neotissue and general characteristics, advantages and disadvantages of each methodology and the landmarks in recent research in the 3D skin bioprinting.

3 November 2025 in Brazilian Journal of Health Review
Verified
Journal Article
Open access
PDF file
GVGuilherme Vendramini Vasconcelos
Guilherme Vendramini Vasconcelos
Lucas Correia PeresLucas Correia Peres
Lucas Correia Peres
CCClara Alves Pires de Castro
Clara Alves Pires de Castro
Letícia FiliceLetícia Filice
Letícia Filice
Cutaneous aging is increasingly being treated with biostimulators such as Poly-L-Lactic Acid (PLLA), Calcium Hydroxylapatite (CaHA), and Polycaprolactone (PCL). Despite their well established use, their distinct molecular mechanisms, by which neocollagenesis is induced, remain under-discussed. This systematic review aims to compare and elucidate the specific mechanisms of these three biostimulators. A literature search was conducted through PubMed for experimental studies (in vivo and in vitro) published between October 2015 and March 2025. Sixteen articles were selected, following the criteria of performing direct comparisons between at least two biostimulators or investigating specific biochemical mechanisms. Scientific literature seems to indicate that PLLA induces collagen synthesis mainly through a complex, inflammation-dependent foreign body reaction involving M2 macrophage polarization, activation of the TGF-β/Smad pathway, mechanotransduction via Piezo1 channels, and lactate-mediated signaling. In contrast, CaHA appears to act primarily through mechanotransduction requiring direct fibroblast contact and calcium ion release, typically eliciting a milder inflammatory response. PCL was found to activate the specific SAMD11-PLOD1 transcriptional axis, promoting collagen maturation. Comparative studies also show that particle morphology significantly influences tissue immunogenicity. While all three agents effectively promote neocollagenesis, they seem to do so through fundamentally different biological pathways. Understanding these unique mechanisms is essential for optimizing the selection of the right bioestimulator and managing their adverse events, although further comparative research is required to address current limitations and deepen our understanding of the neocollagenesis process.